Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,765,778
+$4,163,451 QoQ
Shares Held
2,541,442
+73.8% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 237 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Derivatives in WVE
reported options exposure · as of Mar 31, 2026CallValue
$1,812,500
CallShares
250,000
PutValue
$1,450,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. WVE ranks #22 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in WVE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,765,778 | 2,541,442 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,450,000 | 200,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,812,500 | 250,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $10,602,327 | 1,462,390 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,020,962 | 883,586 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,002,686 | 273,591 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $300,001 | 46,154 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $365,894 | 45,284 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $255,551 | 20,659 | Shares | Defined | 2025-02-14 | |
| 2024-03-31 | $210,699 | 34,149 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $98,434 | 17,119 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $413,056 | 113,477 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $82,148 | 18,972 | Shares | Defined | 2023-05-15 | |
| 2021-09-30 | $98,392 | 20,080 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $229,936 | 34,525 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $388,615 | 69,272 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,110,630 | 141,122 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $801,999 | 94,464 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||